ND-336

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameND-336
Drug Alias NameND-336
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase-2 inhibitorsMatrix metalloproteinase 9 inhibitors +[3] 
TargetsMatrix metalloproteinase 9Matrix metalloproteinase 14Matrix metalloproteinase-2
Therapy Area/IndicationsDiabetic Foot
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Notre Dame
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Notre Dame
Inactive CompaniesN/A
Active IndicationsDiabetic Foot
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A